Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance

Go back to Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance

Repligen (RGEN) Tops Q2 EPS by 27c

July 27, 2021 7:34 AM EDT

Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.79, $0.27 better than the analyst estimate of $0.52. Revenue for the quarter came in at $163 million versus the consensus estimate of $144.1 million.

GUIDANCE:

Repligen sees FY2021 revenue of $625-645 million, versus the consensus of $585.9... More